173 related articles for article (PubMed ID: 21821852)
21. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.
Zaręba W
Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
24. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
25. Health services research in heart failure patients treated with a remote monitoring device in Germany-a retrospective database analysis in evaluating resource use.
Brüggenjürgen B; Israel CW; Klesius AA; Ezzat N; Willich SN
J Med Econ; 2012; 15(4):737-45. PubMed ID: 22409232
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
Sendi P; Günthard HF; Simcock M; Ledergerber B; Schüpbach J; Battegay M;
PLoS One; 2007 Jan; 2(1):e173. PubMed ID: 17245449
[TBL] [Abstract][Full Text] [Related]
27. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
[TBL] [Abstract][Full Text] [Related]
28. A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure.
Postmus D; Pari AA; Jaarsma T; Luttik ML; van Veldhuisen DJ; Hillege HL; Buskens E
Am Heart J; 2011 Dec; 162(6):1096-104. PubMed ID: 22137084
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trial.
Noyes K; Veazie P; Hall WJ; Zhao H; Buttaccio A; Thevenet-Morrison K; Moss AJ
J Cardiovasc Electrophysiol; 2013 Jan; 24(1):66-74. PubMed ID: 22913474
[TBL] [Abstract][Full Text] [Related]
30. Economic assessment of cardiac resynchronization therapy.
Callejo D; Guerra M; Hernández-Madrid A; Blasco JA
Rev Esp Cardiol; 2010 Nov; 63(11):1235-43. PubMed ID: 21070719
[TBL] [Abstract][Full Text] [Related]
31. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of ablation surgery in patients with atrial fibrillation undergoing cardiac surgery.
van Breugel NH; Bidar E; Essers BA; Nieman FH; Accord RE; Severens JL; Vrakking R; Maessen JG
Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):394-8. PubMed ID: 21148666
[TBL] [Abstract][Full Text] [Related]
33. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
[TBL] [Abstract][Full Text] [Related]
34. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
35. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
Pradelli L; Iannazzo S; Zaniolo O
Am J Cardiovasc Drugs; 2009; 9(6):383-92. PubMed ID: 19929036
[TBL] [Abstract][Full Text] [Related]
36. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?
Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE
J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425
[TBL] [Abstract][Full Text] [Related]
37. [Cardiac resynchronization therapy and reduction of mortality in heart failure: a proven association].
Mele D; Toselli T; Pratola C; Artale P; Ferrari R
G Ital Cardiol (Rome); 2007 Dec; 8(12):760-9. PubMed ID: 18085101
[TBL] [Abstract][Full Text] [Related]
38. Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure.
Elsner C; Bettin S; Tilz R; Häckl D
Curr Heart Fail Rep; 2024 Jun; 21(3):186-193. PubMed ID: 38662154
[TBL] [Abstract][Full Text] [Related]
39. Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
Farmer SA; Tuohy EJ; Small DS; Wang Y; Groeneveld PW
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):798-807. PubMed ID: 23093561
[TBL] [Abstract][Full Text] [Related]
40. Modelling the economic and health consequences of cardiac resynchronization therapy in the UK.
Caro JJ; Guo S; Ward A; Chalil S; Malik F; Leyva F
Curr Med Res Opin; 2006 Jun; 22(6):1171-9. PubMed ID: 16846550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
